Stephane Bancel is Chief Executive Officer of Moderna, Inc.. Currently has a direct ownership of 5.49 Million shares of MRNA, which is worth approximately $216 Million. The most recent transaction as insider was on Nov 30, 2022, when has been sold 40,000 shares (Common Stock) at a price of $0.99 per share, resulting in proceeds of $39,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.49M
0% 3M change
1.05% 12M change
Total Value Held $216 Million

Stephane Bancel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 30 2022
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Nov 25 2022
SELL
Open market or private sale
$7,076,400 $176.91 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Nov 25 2022
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Nov 23 2022
SELL
Open market or private sale
$7,092,000 $177.3 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Nov 23 2022
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Nov 17 2022
SELL
Open market or private sale
$7,290,000 $182.25 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Nov 17 2022
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Nov 16 2022
SELL
Open market or private sale
$7,398,000 $184.95 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Nov 16 2022
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Nov 10 2022
SELL
Open market or private sale
$6,628,400 $165.71 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Nov 10 2022
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Nov 09 2022
SELL
Open market or private sale
$6,652,000 $166.3 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Nov 09 2022
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Nov 03 2022
SELL
Open market or private sale
$5,892,000 $147.3 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Nov 03 2022
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Nov 02 2022
SELL
Open market or private sale
$6,081,200 $152.03 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Nov 02 2022
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Oct 27 2022
SELL
Open market or private sale
$5,758,800 $143.97 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Oct 27 2022
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Oct 26 2022
SELL
Open market or private sale
$5,727,200 $143.18 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Oct 26 2022
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Oct 20 2022
SELL
Open market or private sale
$4,858,800 $121.47 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Oct 20 2022
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Oct 19 2022
SELL
Open market or private sale
$5,047,200 $126.18 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Oct 19 2022
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Stephane Bancel

Stephane Bancel

Chief Executive Officer
Cambridge, MA

Track Institutional and Insider Activities on MRNA

Follow Moderna, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

News

Receive news related to Moderna, Inc.

Track Activities on MRNA